Content related to MIBG Combination Therapies Show Promise in Neuroblastoma

Marilyn Smith became a prolific donor in hopes of helping more young cancer patients reach the same positive outcome as her granddaughter.

A CHLA oncologist is leading new research to improve outcomes for children, adolescents and young adults with relapsed or treatment-resistant germ cell tumors.

A CHLA clinical trial finds that N-acetylcysteine may be a promising next-generation therapy to reduce the risk of cisplatin-induced hearing loss.

Three-year-old Javier is happy and healthy and back home in Mexico after successful treatment for neuroblastoma at Children’s Hospital Los Angeles. “We are back to the life we used to have, but we see

A statistical analysis of the largest study cohort to date sheds light on improvements—and gaps—in post-relapse treatment for Acute Lymphoblastic Leukemia.

An international expert at CHLA talks about the state of hemophilia gene therapy—and what’s on the horizon.

Two federal grants are supporting efforts at Children’s Hospital Los Angeles to develop novel therapies for this aggressive childhood brain tumor.

Four investigators share their research—and how the USC/CHLA facility will help bring novel cell therapies to clinical trials faster.

A pilot study at Children’s Hospital Los Angeles is testing whether augmented reality can promote physical activity for children with cerebral palsy.